HomeMDMA • CNSX
add
Pharmala Biotech Holdings Inc
Previous close
$0.11
Day range
$0.11 - $0.12
Year range
$0.085 - $0.33
Market cap
11.95M CAD
Avg Volume
160.33K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | 206.44K | 260.30% |
Operating expense | 498.41K | 3.67% |
Net income | -409.70K | 14.49% |
Net profit margin | -198.46 | 76.27% |
Earnings per share | — | — |
EBITDA | -313.10K | 20.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 901.38K | 353.99% |
Total assets | 3.40M | 29.32% |
Total liabilities | 1.03M | 41.75% |
Total equity | 2.37M | — |
Shares outstanding | 108.89M | — |
Price to book | 5.50 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | -409.70K | 14.49% |
Cash from operations | -116.22K | 51.35% |
Cash from investing | 159.56K | 752.83% |
Cash from financing | — | — |
Net change in cash | 43.34K | 119.62% |
Free cash flow | — | — |
About
Founded
2020
Headquarters
Website
